Covid-19 vaccine

Photo: The Times of India

Booster Dose Duration For Above 18 Year Old Reduced To 6 Months: Union Health Ministry

Amid the rising Covid-19 cases, the Union Health Ministry has reduced gap for COVID-19 precaution doses to six months. Initially, the booster dose for people above 18-year-old was 9 months after being double vaccinated against Covid-19 infection. Furthermore, the changes in duration between vaccination and booster dose came at a time when the nation is recording over 15,000 cases, taking the cumulative active Covid-19 cases to 1,15,212.

Wed, 06 Jul 2022 - 07:40 PM / by Varsha Joshi

Tags: Health Ministry, Covid-19 precaution dose, Duration Reduced, Covid-19 Vaccine, 18 Year Old


Photo: News 18

DCGI Grants EUA For 2 Doses Of ZyCoV-D, COVID Vaccine For Children

The Drugs Controller General of India granted Emergency Use Authorization (EUA) of two doses of ZyCoV-D, a COVID-19 vaccine for children above 12 years old. Manufactured by Zydus Lifesciences limited, the vaccine was used in three doses, for 0,28, and 56 days. However, with the recent approval, ZyCoV-D would now be used in two doses, with a gap of 0-28 days. With this, vaccination time required will be reduced.

Wed, 27 Apr 2022 - 10:13 AM / by Varsha Joshi

Tags: ZyCoV-D Vaccine, Covid-19 Vaccine, DCGI, children, Time Gap

Courtesy: ANI

Covishield and Covaxin

Photo: The Times of India

PGI Chandigarh To Study Covid-19 Vaccine Mixing

The PGI Chandigarh has got the approval of the drug regulator of India to study the mixing of Covid-19 vaccines. The study would help conclude what happens when a person who is fully vaccinated with either Covishield or Covaxin would respond to getting the booster dose of the other vaccine. The purpose of the study is also to compare homologous vaccination to heterologous vaccination.

Sun, 17 Apr 2022 - 12:01 PM / by Varun Das

Tags: Covid-19, Coronavirus Vaccines, Covid-19 Vaccine, Covishield vaccine, Covaxin

Courtesy: The Economic Times

Covid-19 vaccine

Photo: News 18

Covishield Vaccine Prices Slashed To Rs 225, Says Adar Poonawalla

Ahead of the nationwide booster dose COVID-19 vaccination drives, the SII CEO Adar Poonawalla slashed the prices of Covishield from Rs 600 to Rs 225.  On April 9, Poonawalla tweeted, "SII has decided to revise the price of COVISHIELD vaccine for private hospitals from Rs.600 to Rs 225 per dose". Notably, the GoI announced a booster dose for the 18+ population at private vaccination centers in India from… read-more

Sat, 09 Apr 2022 - 05:30 PM / by Varsha Joshi

Tags: SII, Adar Poonawalla, Covid-19 Vaccine, COVISHIELD, Booster Dose

Courtesy: The Times of India

Maharashtra Population

Photo: India Today

100% Eligible Adult Population In Mumbai Vaccinated Against COVID-19: BMC

The Brihanmumbai Municipal Corporation (BMC) confirmed that 100% eligible adult population of Maharashtra capital is vaccinated with double doses of COVID-19 vaccine. On April 7, the BMC tweeted, "Another #MilestoneForMumbai: 100% of the eligible adult population in Mumbai are vaccinated with both Covid-19 doses." Furthermore, Maharashtra reported a massive fall in… read-more

Thu, 07 Apr 2022 - 07:22 PM / by Varsha Joshi

Tags: Maharashtra , BMC, Mumbai population, Covid-19 Vaccine, Vaccination Drive

Bad Taste

Photo: HealthGrades

Vaccine 'Booster' Shots Affect Taste Buds: Study

People who got the booster jab claimed their taste buds have altered, claimed research. Notably, the symptoms were not only experienced by certain age groups but even by healthy people. The shot reportedly tasted like "nickels" and remained the same for a few days. However, experts explained that if a person experiences metallic symptoms immediately after getting the jab, it is normal and there is nothing to worry.

Sun, 06 Feb 2022 - 03:50 PM / by Shaloo Priya

Tags: Health, Covid-19 Vaccine, Booster shot, metallic taste, research

Courtesy: The Times Of India

Covid Test

Photo: Healthline

India Reports 1.61 Lakh Fresh Cases Of COVID-19 & 1.733 Deaths In Last 24 Hours

India reported 1,61,386 new cases of COVID-19 in the last 24 hours, taking the total tally of cases to 4.16 crore, on February 2, according to the Union Health Ministry. The country also recorded 1,733 deaths due to COVID-19 in the last 24 hours, taking the death toll to 4,97,975. About 167.29 crore doses of vaccine have been administered, so far. The daily positivity rate stands at 9.26%.

Wed, 02 Feb 2022 - 12:28 PM / by Shibu Immanuel S

Tags: Covid-19, covid update, COVID-19 daily cases, Union Health Ministry, Covid-19 Vaccine


Photo: The Times Of India

PMPML Deboards 30,000 Non-Vaccinated Passengers From Public Buses: Pune

The Pune Mahanagar Parivahan Mahamandal Limited (PMPML), deboards 30,000 passengers daily for not being vaccinated against COVID-19. The public transport only plies passengers carrying a double-vaccination certificate. “While giving them a ticket, conductors ask the passengers to show their vaccination certificates. If they fail to provide it, they are asked to get down,” informed the traffic manager. Notably, The PMPML’s revenue has declined… read-more

Sun, 23 Jan 2022 - 08:16 PM / by Shaloo Priya

Tags: National, Pune, PMPML Buses, Passengers, Covid-19 Vaccine

Courtesy: The Indian Express


Photo:Times of India

Mansukh Mandaviya Calls COVID-19 Vaccination Drive Successful In World On 1st Year Of Completion

As India completed one year of its COVID-19 vaccination drive on January 16, Union Health Minister Mansukh Mandaviya shared the news. ''This campaign started under the leadership of PM Narendra Modi Ji with everyone's effort, is the most successful vaccination campaign in the world today'', tweeted Mandaviya. He congratulated all the health workers, scientists and countrymen and shared graph of the drive, which successfully administered 156.… read-more

Sun, 16 Jan 2022 - 01:51 PM / by Shaloo Priya

Tags: Covid-19 Vaccine, Mansukh Mandaviya, Health, Twitter, PM Narendra Modi


COVID-19 vaccines

Photo: The Times of India

Central Govt Clears 2 New COVID-19 Vaccine For Emergency Use

Central Government cleared two more vaccine against COVID-19, for emergency use, on December 28. The decision taken during a high-level meeting was welcomed by manufacturers of the two vaccines; CORBEVAX and COVOVAX and an antiviral drug. Notably, CORBEVAX, manufactured by Biological E. Limited passed two Phase III clinical trials on over 3,000 subjects of 18-80 year-old. The company is to begin 100+ million doses from February 2022.

Tue, 28 Dec 2021 - 06:16 PM / by Varsha Joshi

Tags: Covid-19, Covid-19 Vaccine, Biological E, Corbevax, emergency

Courtesy: ANI